BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17665327)

  • 1. Clostridium difficile--Second International Symposium (ICDS).
    Tillotson G
    IDrugs; 2007 Aug; 10(8):538-42. PubMed ID: 17665327
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer.
    Weiss K
    Int J Antimicrob Agents; 2009 Jan; 33(1):4-7. PubMed ID: 18804351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clostridium difficile infections: an unexpected re-emergence].
    Barbut F
    Pathol Biol (Paris); 2008 Feb; 56(1):6-9. PubMed ID: 18178330
    [No Abstract]   [Full Text] [Related]  

  • 4. Clonal spread of a Clostridium difficile strain with a complete set of toxin A, toxin B, and binary toxin genes among Polish patients with Clostridium difficile-associated diarrhea.
    Pituch H; Kreft D; Obuch-Woszczatynski P; Wultańska D; Meisel-Mikołajczyk F; Łuczak M; van Belkum A
    J Clin Microbiol; 2005 Jan; 43(1):472-5. PubMed ID: 15635019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis.
    Kim H; Riley TV; Kim M; Kim CK; Yong D; Lee K; Chong Y; Park JW
    J Clin Microbiol; 2008 Mar; 46(3):1116-7. PubMed ID: 18199783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile.
    Limaye AP; Turgeon DK; Cookson BT; Fritsche TR
    J Clin Microbiol; 2000 Apr; 38(4):1696-7. PubMed ID: 10747174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice.
    Pultz NJ; Donskey CJ
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3529-32. PubMed ID: 16048976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing of Clostridium difficile toxins.
    Giesemann T; Egerer M; Jank T; Aktories K
    J Med Microbiol; 2008 Jun; 57(Pt 6):690-696. PubMed ID: 18480324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile--a new threat to public health?
    Brierley R
    Lancet Infect Dis; 2005 Sep; 5(9):535. PubMed ID: 16156003
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pseudomembranous colitis: pathogenesis, prevention, treatment].
    Zakharova NV; Fil' TS
    Eksp Klin Gastroenterol; 2013; (12):87-91. PubMed ID: 24933996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection of the gut.
    Dodson AP; Borriello SP
    J Clin Pathol; 1996 Jul; 49(7):529-32. PubMed ID: 8813947
    [No Abstract]   [Full Text] [Related]  

  • 12. Chapter 2-12-7. Anaerobic infections (individual fields): antibiotic-associated diarrhea and enterocolitis.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():137-9. PubMed ID: 21728113
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudomembranous colitis caused by toxin A-negative/toxin B-positive variant strain of Clostridium difficile.
    Toyokawa M; Ueda A; Tsukamoto H; Nishi I; Horikawa M; Sunada A; Asari S
    J Infect Chemother; 2003 Dec; 9(4):351-4. PubMed ID: 14691659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile recurrent infection: possible implication of TA systems.
    Gil F; Pizarro-Guajardo M; Álvarez R; Garavaglia M; Paredes-Sabja D
    Future Microbiol; 2015; 10(10):1649-57. PubMed ID: 26439907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of bacterial metabolism and physiology in the pathogenesis of Clostridium difficile disease.
    Bongaerts GP; Lyerly DM
    Microb Pathog; 1997 Apr; 22(4):253-6. PubMed ID: 9140922
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of Clostridium difficile in human pathology].
    Malov VA; Bondarenko VM; Pak SG
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (1):91-6. PubMed ID: 8820690
    [No Abstract]   [Full Text] [Related]  

  • 17. Surgical-site infection with toxin A-nonproducing and toxin B-producing Clostridium difficile.
    Kikkawa H; Miyamoto K; Takiguchi N; Kondo T; Hitomi S
    J Infect Chemother; 2008 Feb; 14(1):59-61. PubMed ID: 18297452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol, it's not just for heart disease anymore.
    Kerzmann A; Feig AL
    ACS Chem Biol; 2006 Apr; 1(3):141-4. PubMed ID: 17163660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile Infection.
    Pollock NR
    J Clin Microbiol; 2016 Feb; 54(2):259-64. PubMed ID: 26659205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.